Professor John Terry

As the Data Co-Lead of the Enabling Technologies theme, Professor John Terry, will drive the Institute’s research strategy and programmes in this theme.

Upon being appointed, Professor Terry said: ‘It is a privilege to take on this important role. I am passionate about creating an environment where technologies play an increasingly important role in understanding the underlying causes of epilepsy as well as advancing approaches to diagnosis and treatment. We will be building an exciting ecosystem that places people with epilepsy at the centre, building bridges between academia, industry and healthcare. Do reach out to get involved in our mission!’

Professor Terry is an Interdisciplinary Professorial Fellow at the University of Birmingham and the director of the Centre for Systems Modelling and Quantitative Biomedicine (SMQB). He is also co-founder and Managing Director of Neuronostics Ltd. Supported by a prestigious EPSRC Established Career Fellowship, Professor Terry’s research transcends traditional disciplinary boundaries speaking to mathematics, computer science, biology and medicine. Professor Terry’s work has deepened our understanding of how seizures emerge from large-scale brain networks and pioneered applications of mathematical models in the context of diagnosis and treatment of epilepsy.

The Epilepsy Research Institute UK’s (ERI) six key research and cross cutting themes are – Neurodevelopment, Disease Modification & Therapeutics, Mortality, Morbidity & Risk, Reproduction & Hormones, Capacity Building and Enabling Technologies. The creation of the themes was informed by the Top Ten priorities of the UK Epilepsy Priority Setting Partnership (PSP) and further scoped and developed by the #Every1EndingEpilepsy research strategy collaborative.

Each research programme will have a dedicated team of theme leads who will be supported by a task force of leading UK scientists and clinicians. Working together, the teams will drive a programme to secure large-scale research investment. This will feed into an overall roadmap for research into epilepsy and will be central to the work of the Institute.